scholarly journals Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study

2019 ◽  
Vol 6 (4) ◽  
pp. 503-520 ◽  
Author(s):  
Mark C. Genovese ◽  
Maria W. Greenwald ◽  
Sergio R. Gutierrez-Ureña ◽  
Mario H. Cardiel ◽  
Jeffrey E. Poiley ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Extension Study ◽  
Severe Rheumatoid Arthritis ◽  
Open Label ◽  
Open Label Extension

scholarly journals Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks. An open-label extension study

1997 ◽  
Vol 40 (10) ◽  
pp. 1843-1851 ◽  
Author(s):  
C. Michael Stein ◽  
Theodore Pincus ◽  
David Yocum ◽  
Peter Tugwell ◽  
George Wells ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Combination Treatment ◽  
Extension Study ◽  
Severe Rheumatoid Arthritis ◽  
Open Label ◽  
Open Label Extension

226. SARILUMAB DOSE REDUCTION IN AN OPEN-LABEL EXTENSION STUDY IN RHEUMATOID ARTHRITIS PATIENTS

Rheumatology ◽  
2017 ◽  
Vol 56 (suppl_2) ◽  
Author(s):  
Mark C. Genovese ◽  
Jon Fay ◽  
Janie Parrino ◽  
Doris Beyer ◽  
Melitza Iglesias-Rodriguez ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Dose Reduction ◽  
Extension Study ◽  
Open Label ◽  
Open Label Extension

scholarly journals An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis

2019 ◽  
Vol 21 (1) ◽  
Author(s):  
Stanley Cohen ◽  
Jose L. Pablos ◽  
Karel Pavelka ◽  
Gerard Anton Müller ◽  
Alan Matsumoto ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Extension Study ◽  
Open Label ◽  
Safety And Efficacy ◽  
Open Label Extension ◽  
Abp 501
Sign in / Sign up

Export Citation Format

Share Document